STAT5 Inhibitor is a cell-permeable, nonpetidic nicotinoyl hydrazone that suppresses STAT5 by targeting its SH2 domain (IC50 = 47 ?M against STAT5?? SH2 domain EPO peptide binding activity).
More Information Supplier PageSAG is a chlorobenzothiophene-containing compound which acts as a SMO agonist (EC50 = 3 nM) but inhibits hedgehog signaling at high concentrations (>1 ??M).
More Information Supplier PageSAG is a chlorobenzothiophene-containing compound which acts as a SMO agonist (EC50 = 3 nM) but inhibits hedgehog signaling at high concentrations (>1 ??M).
More Information Supplier PageSAG is a chlorobenzothiophene-containing compound which acts as a SMO agonist (EC50 = 3 nM) but inhibits hedgehog signaling at high concentrations (>1 ??M).
More Information Supplier Pagecis-Urocanic acid is a major ultraviolet-absorbing component of the stratum corneum.
More Information Supplier Pagecis-Urocanic acid is a major ultraviolet-absorbing component of the stratum corneum.
More Information Supplier Pagecis-Urocanic acid is a major ultraviolet-absorbing component of the stratum corneum.
More Information Supplier PageCeliprolol HCl is a b1 adrenergic receptor antagonist and a b2 adrenergic receptor partial agonist that has been shown to relax human arteries and veins with ED50 values of 40-50 M in vitro.
More Information Supplier PageGly-Phe-beta-naphthylamide is a cathepsin C substrate. The compound is described to accumulate inside lysosomes leading to their destruction.
More Information Supplier Page
